Fellows are invited to apply for a position on the Trainee Council. Trainees who exhibit leadership qualities and a high potential for a successful career in hematology or a hematology-related discipline are desired candidates.
Second-Year Council Members
Council Chair - Marquita Nelson, MD
Dr. Marquita Nelson received her medical degree and completed internal medicine residency at the Emory University School of Medicine. She is currently a second-year hematology/oncology fellow at The University of Chicago. Dr. Nelson’s clinical and research interests include non-malignant hematology and improving the care of adults with sickle cell disease.
Bryan Hambley, MD, MPH
Dr. Bryan Hambley earned his MD and MPH degrees from Tulane University. After residency and chief residency in internal medicine at Case Western, he completed a critical care medicine fellowship at Case Western/University Hospitals. Dr. Hambley is currently a second-year hematology fellow at Johns Hopkins. He plans to practice clinical hematology with a focus on malignant hematology and an emphasis on improving care and access in underserved populations.
Jori May, MD
Dr. Jori May graduated from Washington University in St. Louis School of Medicine before returning to her hometown to complete her residency in internal medicine at the University of Alabama at Birmingham, where she is now a second-year fellow in hematology/oncology. Dr. May plans to pursue a career as a systems-based clinical hematologist, working to improve the care of patients with non-malignant hematologic disorders across health systems.
Daniel Richardson, MD, MA
Dr. Daniel Richardson is a second-year hematology and oncology fellow at the University of North Carolina. In conjunction with a clinical career as a malignant hematologist, focusing on leukemia, his research focuses on cancer outcomes, including unmet needs in cancer care, social and economic disparities, and physician and patient well-being. Dr. Richardson intends to explore ethical issues surrounding the physician-patient relationship, inequities in access and treatment, and the financial consequences of cancer care.
Ze Zheng, MBBS, PhD
Dr. Ze Zheng is an Associate Research Scientist at Columbia University Medical Center in New York. She received her MBBS in clinical medicine from Jiamusi University in China and her PhD in molecular biology and genetics of liver metabolism from Wayne State University in Detroit, Michigan. Dr. Zheng studies the role of reduced hepatocyte-derived fibrinolytic activity in obesity-associated thrombosis. She is interested in pursuing a career in thrombosis-related translational research.back to top
First-Year Council Members
Nicole Cruz, MD
Dr. Nicole Cruz graduated from San Juan Bautista School of Medicine in Puerto Rico and completed her internal medicine residency at Weill Cornell Medicine – New York Presbyterian Hospital in New York, NY where she is currently a third-year hematology/oncology fellow. Dr. Cruz is interested in pursuing a career as a physician-scientist focused in therapeutics development for treatment of acute myeloid leukemia (AML). Dr. Cruz received the ASH HONORS award in 2016 and her research is currently supported by an ASH RTAF award.
Urshila Durani, MD, MPH
Dr. Urshila Durani received her medical degree and Master’s in Public Health from Northwestern University Feinberg School of Medicine. She went on to complete a residency in Internal Medicine at the Mayo Clinic in Rochester, MN. She is currently a third-year chief fellow in hematology/oncology at the Mayo Clinic and will be pursuing an advanced fellowship in stem cell transplant at City of Hope Cancer Center after this year.
Anurekha Gollapudi, MD
Dr. Anu Gollapudi graduated from the University of Toledo College of Medicine and completed her residency in pediatrics at Stanford University. She is currently a second-year fellow in pediatric hematology/oncology at the University of Washington/Seattle Children’s Hospital. Dr. Gollapudi is interested in the effect of health disparities on pediatric cancer outcomes.
Anna Marneth, PhD, MSc
Dr. Anna Marneth is a post-doctoral molecular biologist with a strong interest in myeloid malignancies and platelet disorders. During her PhD at the Radboud University Medical Centre in the Netherlands, she studied gene expression regulation in AML and platelet disorders. Her postdoctoral studies in the Mullally Lab at the Brigham and Women's Hospital, Boston, are focused on the effect of aberrant megakaryopoiesis and RNA splicing on MPN disease progression. The goal of her research is to improve the care of patients with blood disorders by advancing patient diagnostics and performing impactful clinically relevant research.
Sara Taveras Alam, MD
Dr. Sara Taveras Alam graduated from Universidad Iberoamericana (UNIBE) in Dominican Republic and completed her Internal Medicine Residency at Jacobi Medical Center / Albert Einstein College of Medicine where she served as Chief Resident. Dr. Taveras Alam solidified her interest in hematologic malignancies while working as a Hospitalist in Sylvester Cancer Center / University of Miami and she is now a second-year fellow at Baylor College of Medicine in the Houston Medical Center. She is interested in pursuing a career as a clinician educator in malignant hematology.
Lachelle Weeks, MD, PhD
Dr. Lachelle D. Weeks is a fellow in hematology and medical oncology at Dana Farber Cancer Institute. She earned her MD and PhD degrees from Case Western Reserve University prior to completing internal medicine residency at Brigham and Women’s hospital. Dr. Weeks’s clinical and research interests are focused on understanding clonal hematopoiesis and development of secondary hematologic malignancies in cancer survivors.
back to top